These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25419776)

  • 1. Prevalence of and risk factors for vancomycin-resistant Staphylococcus aureus precursor organisms in Southeastern Michigan.
    Albrecht VS; Zervos MJ; Kaye KS; Tosh PK; Arshad S; Hayakawa K; Kallen AJ; McDougal LK; Limbago BM; Guh AY
    Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1531-4. PubMed ID: 25419776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in Southeastern Michigan.
    Tosh PK; Agolory S; Strong BL; Verlee K; Finks J; Hayakawa K; Chopra T; Kaye KS; Gilpin N; Carpenter CF; Haque NZ; Lamarato LE; Zervos MJ; Albrecht VS; McAllister SK; Limbago B; Maccannell DR; McDougal LK; Kallen AJ; Guh AY
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):954-60. PubMed ID: 23917910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. pSK41-like plasmid is necessary for Inc18-like vanA plasmid transfer from Enterococcus faecalis to Staphylococcus aureus in vitro.
    Zhu W; Clark N; Patel JB
    Antimicrob Agents Chemother; 2013 Jan; 57(1):212-9. PubMed ID: 23089754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin-resistant Staphylococcus aureus isolates associated with Inc18-like vanA plasmids in Michigan.
    Zhu W; Clark NC; McDougal LK; Hageman J; McDonald LC; Patel JB
    Antimicrob Agents Chemother; 2008 Feb; 52(2):452-7. PubMed ID: 18056272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-resistant Staphylococcus aureus, Michigan, USA, 2007.
    Finks J; Wells E; Dyke TL; Husain N; Plizga L; Heddurshetti R; Wilkins M; Rudrik J; Hageman J; Patel J; Miller C
    Emerg Infect Dis; 2009 Jun; 15(6):943-5. PubMed ID: 19523298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ceftaroline pharmacodynamic activity versus community-associated and healthcare-associated methicillin-resistant Staphylococcus aureus, heteroresistant vancomycin-intermediate S. aureus, vancomycin-intermediate S. aureus and vancomycin-resistant S. aureus using an in vitro model.
    Zhanel GG; Rossnagel E; Nichol K; Cox L; Karlowsky JA; Zelenitsky S; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2011 Jun; 66(6):1301-5. PubMed ID: 21429940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative genomics of vancomycin-resistant Staphylococcus aureus strains and their positions within the clade most commonly associated with Methicillin-resistant S. aureus hospital-acquired infection in the United States.
    Kos VN; Desjardins CA; Griggs A; Cerqueira G; Van Tonder A; Holden MT; Godfrey P; Palmer KL; Bodi K; Mongodin EF; Wortman J; Feldgarden M; Lawley T; Gill SR; Haas BJ; Birren B; Gilmore MS
    mBio; 2012; 3(3):. PubMed ID: 22617140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006.
    Sievert DM; Rudrik JT; Patel JB; McDonald LC; Wilkins MJ; Hageman JC
    Clin Infect Dis; 2008 Mar; 46(5):668-74. PubMed ID: 18257700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA; Beaulieu S; Arhin FF; Belley A; Sarmiento I; Parr T; Moeck G
    J Antimicrob Chemother; 2009 Jun; 63(6):1191-9. PubMed ID: 19369269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of infection and colonization with vancomycin-resistant enterococci and frequency of cocolonization with methicillin-resistant Staphylococcus aureus in children.
    Benson L; Sprague B; Campos J; Singh N
    Infect Control Hosp Epidemiol; 2007 Jul; 28(7):880-2. PubMed ID: 17564995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of chlorhexidine and povidone iodine activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis using a surface test.
    Block C; Robenshtok E; Simhon A; Shapiro M
    J Hosp Infect; 2000 Oct; 46(2):147-52. PubMed ID: 11049709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for and epidemiology of community-onset vancomycin-resistant Enterococcus faecalis in southeast Michigan.
    Omotola AM; Li Y; Martin ET; Alshabani K; Yadav D; Sarkar M; Thapa SD; Kumar V; Mahabashya A; Ahmad S; Bhargava A; Marchaim D; Pogue JM; Rybak MJ; Kaye KS; Hayakawa K
    Am J Infect Control; 2013 Dec; 41(12):1244-8. PubMed ID: 24011554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin-resistant Staphylococcus aureus--New York, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Apr; 53(15):322-3. PubMed ID: 15103297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of vancomycin-resistant Staphylococcus aureus identified in the Tlemcen university hospital (North-West Algeria).
    Rebiahi SA; Abdelouahid DE; Rahmoun M; Abdelali S; Azzaoui H
    Med Mal Infect; 2011 Dec; 41(12):646-51. PubMed ID: 22033230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus resistant to vancomycin--United States, 2002.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 Jul; 51(26):565-7. PubMed ID: 12139181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nosocomial infection caused by methicillin-resistant Staphylococcus aureus in Palestine.
    Adwan K; Abu-Hasan N; Adwan G; Jarrar N; Abu-Shanab B; Abu-Zant A
    Microb Drug Resist; 2005; 11(1):75-7. PubMed ID: 15770099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus.
    Hayakawa K; Marchaim D; Vidaillac C; Lephart P; Pogue JM; Sunkara B; Kotra H; Hasan A; Shango M; Yerramalla Y; Osunlana AM; Chopra T; Dhar S; Salimnia H; Rybak MJ; Kaye KS
    Infect Control Hosp Epidemiol; 2011 Sep; 32(9):922-4. PubMed ID: 21828976
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical correlates of vancomycin-resistant enterococci/meticillin-resistant Staphylococcus aureus co-colonization and co-infection in Singapore.
    Kurup A; Wong YY; Tan KY; Low JG
    J Hosp Infect; 2008 Nov; 70(3):291-2. PubMed ID: 18804897
    [No Abstract]   [Full Text] [Related]  

  • 20. Trafficking of methicillin-resistant staphylococci and co-colonization with vancomycin-resistant enterococci.
    Sharaf EJ; Senok AC; Udo EE; Botta GA
    Med Princ Pract; 2011; 20(3):253-8. PubMed ID: 21454996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.